Gemstone BioTherapeutics, LLC — Form D
Gemstone BioTherapeutics, LLC of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-27. The offering totals $3.5M, of which $700K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-10-27
- Form: D
- Accession: 0001014100-16-000052
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $700K
- Remaining: $2.8M
- Minimum investment: $100K
- Investors: 5
- Date of first sale: 2016-10-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273320
Issuer
- Name: Gemstone BioTherapeutics, LLC
- CIK: 0001644667
- Entity type: Limited Liability Company
- Jurisdiction: MARYLAND
- Incorporated: 2013
- Address: 180 W. OSTEND STREET, BALTIMORE, MD, 21230
- Phone: 443-873-7010
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| George Davis | Director | Albany, NY |
| XIN HUANG | Director | Watertown, MA |
| Geoff MacKay | Director | Toronto, A6 |
| David Oros | Director | Bethesda, MD |
| George Davis | Executive Officer | Albany, NY |
| George Davis | Promoter | Albany, NY |
| David Oros | Promoter | Bethesda, MD |
| Sharon Gerecht | Director | Baltimore, MD |
Other filings by this issuer (1)
More